Support and Resistance Levels
Past performance
About Samsrita Labs Ltd Samsrita Labs Limited, formerly Dr Habeebullah Life Sciences Limited, was established on January 25, 1996. The company, which underwent a name change in October 2022, initially focused on stem cell hospitals, molecular diagnostics, and new drug discovery. However, it has since shifted its focus to the bio-pharma sector, engaging in trading, exporting, and importing of medicinal drugs, chemicals, and reagents, as well as manufacturing bulk drugs and APIs through various partnerships. In 2017, the company expanded its scope to include new drug discovery, clinical research, stem cell research and therapy, biotechnology R&D, and nutraceutical product development.
Samsrita Labs is noted for its commitment to innovation in healthcare, particularly in stem cells and regenerative medicine. It has collaborative agreements for developing treatments for NASH and Wilson Disease and operates a multi-specialty stem cell hospital. The company also offers academic services related to biotechnology and pharma. Samsrita Labs is established as a leading research center in stem cell R&D, new drug discovery, and molecular diagnostics.